News

Massachusetts General Hospital scientists have, for the first time, shown that oxygen restriction increases lifespan in a mouse model of aging. The research is published in PLOS Biology.

Researchers have led a clinical trial on a new treatment which can help people stop needing to use opioid painkillers to manage chronic pain.

Inflammatory fatty liver disease and the resulting liver cancer are driven by autoaggressive T cells. Scientists now show what is behind this destructive behavior.

Altered version of anti-nausea drug netupitant reaches inside cells to disrupt signaling and provide sustained pain relief.

Over time, the body's cells stop working properly and begin to accumulate, which eventually leads to aging. Now, researchers have discovered a new molecule that is able to destroy these old cells without affecting the healthy ones.

Researchers have developed a new method to help improve drug delivery in chronic wounds that have been infected with Staphylococcus aureus.

Scientists from the University of California San Francisco (UCSF) have, for the first time, recorded pain-related data from the brains of patients with chronic pain conditions.

Results of a Phase 2a clinical trial suggest that peresolimab, an antibody that stimulates the human programmed cell death protein 1 (PD-1) pathway, could be a promising new approach for the treatment of rheumatoid arthritis.

Transthyretin-related cardiac amyloidosis is a progressive disease characterized by the deposition of amyloid protein fibrils in the heart.

The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington’s disease, when compared to a placebo, according to a recent international study.